FRANKFURT – On Tuesday, Bayer struck a collaboration deal with U.S. biotech firm Cytokinetics (NASDAQ: CYTK) to acquire certain rights
1 year ago
MADRID – On Tuesday, Grifols (NASDAQ: GRFS) said that Canadian investment fund Brookfield’s potential 6.45 billion euro ($6.8 billion) offer
Medtronic (NYSE: MDT) lifted the lower end of its annual profit forecast for a second time on Tuesday, banking on
MADRID – An investigating magistrate at Spain’s High Court has opened a probe into U.S.-based short seller Gotham City Research’s
On Tuesday, Dexcom (NASDAQ: DXCM), the medical device maker, said it will invest $75 million in Ōura’s latest funding round,
U.S. government health plans account for the lion’s share of coverage for popular new weight-loss drugs, far beyond the reimbursement
HOUSTON – CareMax (NASDAQ: CMAX), which operates 56 medical centers in Florida, Texas, Tennessee, and New York catering largely to
Brookfield (NYSE: BN), the Canadian fund, plans to offer about 7 billion euros ($7.4 billion) for Spanish drugmaker Grifols (NASDAQ:
On Thursday, Halozyme Therapeutics (NASDAQ: HALO) said it has proposed to buy German drug developer Evotec (NASDAQ: EVO) for about
On Thursday, Smith & Nephew (NYSE: SNN) said it was confident it was on the right course after the Financial
The city of Baltimore won $266 million in its lawsuit accusing top drug distributors McKesson (NYSE: MCK) and Cencora (NYSE:
BRUSSELS/LONDON – EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of
